Heather M Stieglitz, PhD, is a American Board of Clinical Chemistry certified Co-Director of Clinical Chemistry and Toxicology and Clinical Assistant Professor in the Pathology Department of the Ohio University Wexner Medical Center. Dr. Stieglitz completed her training in clinical chemistry in the COMACC accredited fellowship at the Department of Pathology and Laboratory Medicine at the University of North Carolina School of Medicine. She is Medical Director for point of care testing at OSU Outpatient Care East, OSU Outpatient Care Lewis Center, and OSU Outpatient Care Gahanna. Dr. Stieglitz's research interests are in interferences in clinical testing, general chemistry, toxicology, and point of care testing.
Academic and Medical Appointments
2019-Present Clinical Assistant Professor, Department of Pathology, The Ohio State University Wexner Medical Center
2019-Present Co-Director of Clinical Chemistry and Toxicology
2019-Present Medical Director of OSU Outpatient Care East Laboratory, OSU Outpatient Care Lewis Center, OSU Outpatient Care Gahanna
Education and Training
2017-2019 Clinical Chemistry Fellow, The University of North Carolina Hospitals, Chapel Hill, North Carolina
2010-2012 Post-doctoral Fellow, New York University Langone Medical Center, New York, New York
2005-2010 PhD, Emory University, Atlanta, Georgia
2000-2004 B.S, John Carroll University, University Heights, Ohio
Search in PubMed
- Stieglitz H and Cotten S. Kratom, a novel herbal opioid in a patient with benzodiazepine use disorder. Toxicology Cases for the Clinical and Forensic Laboratory.
- Stieglitz H and Korpi-Steiner N. Characterization of biotin interference in 21 Vitros 5600 immunoassays and risk mitigation for patient safety at a large academic medical center. Clin Biochem. (In press).
- Stieglitz HM, Korpi-Steiner N, Katzman B, Mersereau JE, Styner M. Suspected Testosterone-Producing Tumor in a Patient Taking Biotin Supplements.J Endocr Soc. 2018 May 10;2(6):563-569.
- Leahy P, Stieglitz H, Maher E, Smith L, Korpi-Steiner N. High anion gap metabolic acidosis in a neonate: An organic acid profile of “peaking” interest. ASCP Case Reports 2017, ASCP Case Reports 2017; CC17(6):1-22.
- Beaumel S, Picciocchi A, Debeurme F, Vivès C, Hesse AM, Ferro M, Grunwald D, Stieglitz H, Thepchatri P, Smith SME, Fieschi F, Stasia MJ. Down-regulation of NOX2 activity in phagocytes mediated by ATM-kinase dependent phosphorylation. Free Radic Biol Med. 2017 Dec;113:1-15.
- Wang DN, Stieglitz H, Marden J, Tamm LK. Benjamin Franklin, Philadelphia’s favorite son, was a membrane biophysicist. Biophys. J. 2013. Jan 22;104(2):287-91.
- Kawahara T, Jackson HM, Smith SM, Simpson PD, Lambeth JD. Nox5 forms a functional oligomer mediated by self-association of its dehydrogenase domain. Biochemistry. 2011. Mar 29;50(12):2013-25.
- Jackson HM, Kawahara T, Nisimoto Y, Smith SE, Lambeth JD. The Nox4 B-loop creates an interface between the transmembrane and dehydrogenase domains. J. Biol. Chem. 2010. Apr 2;285(14):10281-90.
- Nisimoto Y*, Jackson HM*, Ogawa H, Kawahara T, Lambeth JD. Constitutive NADPH-Dependent Electron Transferase Activity of the Nox4 Dehydrogenase domain. Biochemistry. 2010. Mar 23;49(11):2433-42.
- Daneshvar H, Nelms J, Muhammad O, Jackson H, Tkach J, Davros W, Peterson T, Vogelbaum MA, Bruchez MP, Toms SA. Imaging characteristics of zinc sulfide shell, cadmium telluride core quantum dots. Nanomedicine (Lond). 2008. 3(1):21-9.
- Jackson H, Muhammad O, Daneshvar H, Nelms J, Popescu A, Vogelbaum MA, Bruchez M, Toms SA. Quantum Dots are phagocytized by macrophages and colocalize with experimental gliomas Neurosurgery, 2007. 60(3): 524-530.